Abstract: In vivo modelling of the pathogenesis of HIV-1 in plasma captures the interplay of the virus and CD4 cells in the cell-free viral spread process. Modelling is also done for both in vitro cell-to-cell and cell-to-free viral spread of HIV-1 and its kinetics in tissue cultures. Upon infection with HIV-1, there is a short intracellular "eclipse phase" or "latency", during which the cell is infected but has not yet begun producing virus. One approach to account for the "eclipse phase" or "latency" is to introduce an intracellular delay in the models. This paper focuses on the identifiability of the parameters in the most popular HIV models with time delay, in vivo and in vitro. The identifiability of such parameters as the time-delay parameter; the effective reproductive rate of healthy cells; death rate of infected cells; average life time of productively infected cells; viral burst size; etc, is studied by the linear algebraic method based on differential 1-form. Medical interpretation for the identifiability results is given, and it provides guidelines in data collection for the identification of these parameters.
INTRODUCTION AND A REVIEW OF HIV MODELS
The markers of the disease progression due to the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS) are the CD4 cell and viral levels in the plasma. The interplay of the CD4 cells and virus is better revealed during the early process of cellular infection and viral production as well as the post therapeutical period of viral suppression and immunological recovery. Mathematical models have been proposed to describe the immunological response to HIV infection, with HIV dynamics in vivo data verification and extraction of key parameters of the dynamics (see Ho et al [1995] , Wei, et al [1995] , Nowak and May [2000] , Perelson and Nelson [1999] and references therein).
The need of a full set of HIV model parameters is recognized in the approach of model identifiability and parameter identification taken by Xia and Moog [2003] , Jeffrey and Xia [2005] , Jeffrey et al [2003] , as well as the applications in studies of vaccine readiness in Southern Africa (Filter et al [2003] , Gray et al [2005] ), drug effectiveness and therapy failures on existing patients in France (Ouattara [2005] , Ouattara et al [2004] (see also the summary report given in Xia [2007] )).
Investigation of in vitro cell-to-cell spread of HIV is important since majority of infection occurs in the lymphatic tissues where 98% of CD 4+ lymphocytes reside (Rosenberg and Janossy [1999] ) on the one hand, and many features are easier to determine experimentally in tissue cultures than in plasma (Culshaw et al [2003] ) on the other hand. A modeling approach was proposed by Spouge et al A short intracellular "eclipse phase" or "latency" is observed during the infection stage and post therapeutical response. During early infection, the cell is infected but
has not yet started producing virus. While in response to therapeutical treatment with highly active antiretroviral therapy (HAART), the virus is not suppressed until a "shoulder period" of time. There are two approaches to model this eclipse phase, by a time delay or by an explicit class of latently infected cells, and Perelson and Nelson [1999] has taken the approach of modeling with an explicit class of latently infected cells. The first paper of taking the "delay" approach is Herz et al [1996] where it is assumed that cells become productively infected τ time units after initial infection. Tam [1999] has taken up the investigation of introducing a delay in modeling the interaction between the replicating virus and host cells.
Properties of these models in terms of stability and steady states are studied for clinically reported parameter values (Culshaw and Ruan [2000] , Lloyd [2001] ). Extensions are done in Mittler et al [1998] for a distributed delay, and in Nelson et al [2001 Nelson et al [ , 2000 , Nelson and Perelson [2002] , Dixit and Perelson [2004] to include delays in HIV infection and treatment for more general cases of combination antiviral drugs with/without reduced efficacy. A "delayed" version of the cell-to-cell in vitra model of Spouge et al [1996] was also proposed by Culshaw et al [2003] .
At the theoretical front of identifiability, concepts and algorithmic procedures are developed (Zhang et al [2006] ) for non-linear models with pointwise delays under the general framework of non-commutative module approach (Xia et al [2002] ). This paper focuses on the identifiability of the parameters in the most popular HIV models with time delay, in vivo and in vitro. These parameters, which include the time-delay parameter; the effective reproductive rate of healthy cells; death rate of infected cells; viral burst size; etc, are studied by the algebraic method in Zhang et al [2006] . After deriving the identifiability results, the corresponding medical interpretations, which give guidelines in data collection for parameter identification, are provided.
The layout of the paper is as follows. The next section gives a quick review on the parameter identifiability results for nonlinear time-delay systems. Section 3 provides the identifiability of delay and other parameters of three HIV models. The last section is the conclusion.
PRELIMINARIES
For the readers' convenience, some results on the identifiability of delay parameter, and the algebraic and geometric identifiability of other system parameters from Anguelova and Wennberg [2006] and Zhang et al [2006] are recalled. Consider the following nonlinear time-delay systeṁ
where
, f, h, φ, u 0 are meromorphic, and θ is a parameter. When θ is known and s = 1, Anguelova and Wennberg [2006] defines the identifiability of the delay parameter under the framework of non-commutative modules (Xia et al [2002] ) as the following. Definition 1. (Anguelova and Wennberg [2006] ) Assume that s = 1 and θ is known in (1). The delay parameter τ is said to be locally identifiable at
, there exist t 0 and a smooth input u such that y(t; φ 1 , u, τ 1 ) = y(t; φ 0 , u, τ 0 ), where y(t; φ, u, τ ) denotes the output for the initial function φ, the input u and delay τ . Let Z 0 be the set of nonnegative integers, and K the field of meromorphic functions of a finite number of variables in the set {x(t − iτ ), θ, u (j) (t − iτ ) : i, j ∈ Z 0 }. Define δ to be the shift operator such that δ(a(t)) = a(t − τ ). Let K(δ] be the noncommutative ring which is defined as the set of polynomials in δ with coefficients in K ( Xia et al [2002] ).
The following is a partial result on the identifiability of τ in Anguelova and Wennberg [2006] which will be used in this paper. Theorem 1. (Anguelova and Wennberg [2006] ) Assume that s = 1, θ is known, and the observability index of system (1) is (s 1 , s 2 , · · · , s p ), then the delay parameter τ is locally identifiable if the rank of M , are referred to Xia and Moog [2003] . Let P be the range of θ and define
Definition 2. (Zhang et al [2006] ) The parameter θ in system (1) is said to be geometrically identifiable if there exist a T > 0, an integer k 0, an open subset S 1 of W k , a function φ which is meromorphic in its arguments, (ii) The parameter θ in (1) is geometrically identifiable if and only if dθ ∈ (X + Y + U) holds for all (θ, x 0 , u) ∈ S, where S is an open subset of some W k .
Roughly speaking, the algebraic identifiability of the parameter θ means that θ can be represented by some meromorphic function of the output y and its derivatives and delays, while the geometric identifiability of θ means θ can be represented as a function of x and y, and their derivatives and delays. Therefore the algebraic and geometric identifiability can be tested by the computation of derivatives of y, or equivalently, the derivatives of dy, to see if the conditions in the above Theorem 2 hold (see Theorem 2 and 3 of Zhang et al [2006] for computing details). That is, one needs to compute y 
MAIN RESULTS
This section considers two dimensional in vitro HIV model, and three and four dimensional in vivo HIV models. The detailed computation for the two and three dimensional models is omitted since the technique is similar to the four dimensional case in subsection 3.3 and Xia and Moog [2003] .
2-dimensional in vitro model
The following is a 2-dimensional HIV in vitro model from Culshaw et al [2003] :
where C(t) is the concentration of healthy cells, I(t) is the concentration of infected cells, r C is the effective reproductive rate of healthy cells, C M is the effective carrying capacity of the system, k I is the infection of healthy cells by the infected cells,
is the fraction of cells surviving the incubation period, µ I is the death rate of infected cells, and τ is the time delay. The output is y(t) = C(t) + I(t). Let
The delay τ can be identified by using Theorem 1. Proposition 1. Assume that θ is known and the following persistent exciting conditions hold: (3) is locally identifiable. Now suppose the delay parameter τ is known and consider the identifiability of θ. It is obvious that dẏ = a 1 dθ + (a 2 + a 3 δ)dx 1 + (a 4 + a 5 δ)dy, where
where c 1 , · · · , c 9 ∈ K are defined obviously by the above equality, and c 9 = 0. By using dδx 1 = δ(dx 1 ) one has
:= e 1 dθ + e 2 dy + e 3 dδy + e 4 dẏ + e 5 dδẏ. For k 3, it is easy to compute that
dθ + [e 2 dy + e 3 dδy + e 4 dẏ + e 5 dδẏ] (k−2) . Now the following proposition follows. Proposition 2. Assume that the delay parameter τ in system (3) is known, a 2 b 3 − a 3 b 2 = 0, and the matrix
1 )
T is of rank 5, then the five parameters r C , C M , k I , k I and µ I are all algebraically identifiable and hence geometrically identifiable. Remark 1. The above proposition means that when the delay parameter τ is given and some persistent exciting conditions hold, then the five parameters in (3) can be determined by the measured values {y (i) (t), y (j) (t − τ ) : i = 0, 1, · · · , 6; j = 0, 1, · · · , 5} for any fixed time t. Even if the delays are ignored, one has to measure 7 times to obtain y,ẏ, · · · , y (6) . Therefore the measurement has to be taken at least 7 times. These persistent exciting conditions are satisfied roughly at the rapid changing infection and replication stages. Model (3) describes an infection taking place in the culture tissues in a wellcontrolled laboratory environment, and the above needed measurements of the derivatives and delays of the output can usually be completed within one or two days, therefore the five parameters are determined accordingly.
3-dimensional in vivo model
The following is a 3-dimensional HIV in vivo model with time delay:
where T is the density of uninfected CD4 cell lymphocytes (or target cells), which are generated at a rate λ and die with a first order rate constant d when there is no infection. When there is virus, T * is the density of infected cells, k is the second order rate constant of infection, V is the viral load. The parameter 1 δ is average lifetime of productively infected cells, N is the viral burst size, c is a first order rate constant that free virions are cleared with, 1 m is the average lifetime of infected cells before they become productive, and τ is the fixed intracellular delay (see Dixit and Perelson [2004] ). The following are the outputs y 1 (t) = T (t), y 2 (t) = V (t).
Let
T , then system (5) can be rewritten aṡ
By computing rank K ∂(y1,y2,ẏ2,ÿ2) ∂(x1,x2,x3,x1(t−τ ),x3(t−τ )) and rank K(δ] ∂(y1,y2,ẏ2) ∂(x1,x2,x3) , one has the following result. Proposition 3. Assume that θ is known in (5), and kδN x 1 (t − τ ) = 0 or kδN x 3 (t − τ ) = 0, then the delay parameter τ in system (5)- (6) is locally identifiable. Now consider the algebraic identifiability of θ when τ is given. Sinceẏ
the parameters θ 1 , θ 2 , θ 3 are algebraically identifiable when
The identifiability of the remaining parameters θ 4 , θ 5 , · · ·, θ 7 follows from y 2 (t) = θ 3 θ 4 θ 5 e −θ7τ y 1 (t − τ )y 2 (t − τ ) − (θ 4 + θ 6 )ẏ 2 −θ 4 θ 6 y 2 .
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hold for system (5)-(6).
(i) If m and τ are given, then all the remaining parameters λ, d, k, δ, N, C are algebraically identifiable;
(ii) If τ is given, then all the parameters m, λ, d, k, δ, N, C are geometrically identifiable. Remark 2. The above proposition shows that when m and τ are given and some persistent exciting conditions hold, then all the parameters in (5) can be determined by the measurement of {y (i) (t), y (j) (t − τ ) : i = 0, 1, · · · , 4; j = 0, 1, 2} for any fixed time t. Even if the delays are ignored, one has to measure at least five times to obtain y,ẏ, · · · , y (4) .
Although the output (6) for system (5) is often available for post-treatment, the following output is easier to be measured and hence studied here:
The identifiability of the delay parameter τ can be considered similarly as above, and the following result is obtained. Proposition 5. If kδN x 3 (t − τ ) = 0 or kδN x 1 (t − τ ) = 0 in system (5)- (10), and the parameter θ is given, then the delay parameter τ is locally identifiable.
Now consider the identifiability of θ under the output (10).
The following relation is obtained by some computation: y 2 = ξ 1 + ξ 2 y 1 + ξ 3 y 1 y 2 + ξ 4 y 2 + ξ 5 y 2 2 + ξ 6ẏ2 + ξ 7 y 2ẏ2 +ξ 8ẏ1 , where ξ 1 = −θ 1 θ 4 θ 5 , ξ 2 = θ 2 θ 4 θ 5 , ξ 3 = θ 3 θ 4 θ 5 , ξ 4 = −θ 2 θ 6 , ξ 5 = −θ 3 θ 6 , ξ 6 = −(θ 2 + θ 6 ), ξ 7 = −θ 3 , ξ 8 = θ 4 θ 5 . Therefore y
, k 1. Proposition 6. Assume that τ is given in system (5) with output (10). If the rank of the following matrix
over K is 7, then θ 1 , θ 2 , θ 3 , θ 4 θ 5 , θ 6 are algebraically identifiable. If furthermore θ 7 is given and θ 4 θ 5 = 0, then all the parameters θ 1 , θ 2 , θ 3 , θ 4 , θ 5 , θ 6 are algebraically identifiable and hence geometrically identifiable. Remark 3. The condition θ 4 θ 5 = N δ = 0 holds in general. Now it follows from the above proposition that when m is given, then the parameters λ, d, k, N δ, c, m in (5) can be determined by the measured values {y (i) (t) : i = 0, 1, · · · , 9} for any fixed time t. If, furthermore, y 1 (t − τ ), y 2 (t − τ ),ẏ 2 (t − τ ) are known for some time t, then it is easy to show that N and δ can be determined.
4-dimensional in vivo model
The following is the 4-dimensional in vivo HIV model from Dixit and Perelson [2004] 
with the output
where V 1 and V 2 are infectious and non-infectious viral load respectively, is the instantaneous efficacy of the protease inhibitors and has been assumed to be constant in this paper, and all the other variables and parameters have the same meaning as the 3-dimensional in vivo model (5). Let (12) is rewritten aṡ
The identifiability of the delay parameter τ follows from the following computation.
The following matrix
when θ 3 θ 4 θ 5 x 1 (t)x 3 (t−τ ) = 0 or θ 3 θ 4 θ 5 x 1 (t) x 1 (t−τ ) = 0. It follows from Theorem 1 that τ is identifiable. Now the following result is obtained. Proposition 7. Assume that the parameter θ is known in system (12)- (13), then the delay parameter τ is locally identifiable if kδN x 1 (t)x 3 (t − τ ) = 0 or kδN x 1 (t)x 1 (t − τ ) = 0 . Now consider the algebraically identifiability of θ under the condition that τ is given. It is easy to compute that
17th IFAC World Congress (IFAC'08) Seoul, Korea, July 6-11, 2008 (15) then the parameters (θ 2 θ 4 θ 5 e −θ7τ , θ 4 θ 5 e −θ7τ , θ 4 + θ 6 , θ 4 θ 6 ) are algebraically identifiable. By the expression ofÿ 2 , the parameters θ 1 , θ 2 , θ 4 , θ 5 e −θ7τ , θ 6 are algebraically identifiable if θ 4 θ 5 = 0. If, furthermore, y 1ẏ2 + θ 6 y 2 = 0, then θ 3 (1−θ 8 ) is also algebraically identifiable by the expression ofÿ 1 . The geometric identifiability of θ 3 and θ 5 follows from
Proposition 8. In the system (12)- (13), assume that τ is given, the persistent exciting condition (15) holds, then θ 2 , θ 4 , θ 6 and θ 5 e −θ7τ are algebraically identifiable. If, furthermore, θ 4 θ 5 = 0, then θ 1 is algebraically identifiable, and so is θ 3 (1 − θ 8 ) when y 1ẏ2 + θ 6 y 2 = 0. When all the above conditions for algebraically identifiability hold, and θ 4 y 1 x 2 x 3 = 0 for some time t, then all the parameters θ 1 , θ 2 , · · · , θ 8 are geometrically identifiable. Remark 4. When m, and τ are given and some persistent exciting conditions hold, then all the parameters in (12) can be determined by the measurement of {y Now consider the second type of output for system (12):
The delay parameter τ is also identifiable by a similar computation. Proposition 9. For system (12) with output (16) and known parameter θ, the delay parameter τ is locally identifiable if kδN x 3 (t)x 3 (t − τ ) = 0 or kδN x 1 (t)x 1 (t − τ ) = 0.
Now consider the identifiability of θ when τ is given. Let Γ 11 = 0, 0, 0,
Thuṡ
or equivalentlÿ y 2 = −θ 1 θ 4 θ 5 + θ 2 θ 4 θ 5 x 1 + θ 3 θ 4 θ 5 x 1 x 3 + θ 2 4 θ 5 x 2 +θ 4 θ 5ẏ1 − (θ 4 + θ 6 )ẏ 2 − θ 4 θ 6 y 2 . If one computesÿ 2 directly by definition, then a delay parameter τ appears, while the above obtainedÿ 2 does not contain τ , which simplifies some late computation.
By finding differentials of the aboveÿ 2 , one has dÿ 2 = Γ 21 dθ + Γ 22 dx 1 + θ 2 4 θ 5 dx 2 + θ 3 θ 4 θ 5 x 1 dx 3 +θ 4 θ 5 dẏ 1 − (θ 4 + θ 6 )dẏ 2 − θ 4 θ 6 dy 2 = Γ 31 dθ + θ 3 θ 4 θ 5 x 1 dx 3 + Γ 32 dẏ 2 + Γ 33 dy 2 + Γ 34 dẏ 1 +Γ 35 dy 1 , where
Now it is ready to compute dy is easily computed by the above dy 2 ), where µ j , τ j , j = 0, · · · , k + 2, are coefficients which can be determined by Γ 6i , i = 1, 2, · · · , 7. Note that Γ 61 =Γ 31 + θ6x1−ẋ1 x1
Γ 31 + θ 3 θ 4 θ 5 x 1 Γ 50 , thus the 7-th column of Γ 61 is zero, and the following result is obvious from Theorem 2. Proposition 10. Assume that τ is given in system (12) T = 7, then θ 1 , θ 2 , θ 3 , θ 4 , θ 5 , θ 6 , θ 8 are algebraically identifiable, and hence geometrically identifiable. Remark 5. When m, and τ are given and some persistent exciting conditions hold, then all the parameters in (12) can be determined by the measurement of {y 17th IFAC World Congress (IFAC'08) Seoul, Korea, July 6-11, 2008 For the 3-dimensional and 4-dimensional in vivo models (5) and (12), the identifiability conditions of the delay parameter τ are given in Proposition 3, 5, 7, and 9, and the conditions are quite similar and have reasonable medical meanings. In fact, if k = 0, then infection does not take place; if δN = 0, then virus replication does not happen; x 1 = 0 corresponds to completely damaged immune system; and x 3 = 0 indicates no (infectious) free virus. In these cases, either the time delay does not matter or it is "invisible". Proposition 4, 6, 8, and 10 give persistent exciting conditions for the algebraic identifiability of θ.
The most likely period for these conditions to hold is either the primary infection stage or the not-too-short period after disturbing the asymptomatic period through chemotherapy.
CONCLUSION
The identifiability of parameters in two dimensional HIV in vitro model, three and four dimensional HIV in vivo models are discussed in this paper by the linear algebraic method based on differential 1-form. For the in vivo models, two types of outputs are considered. The identifiability of delay parameters and the algebraic and geometric identifiability of other parameters are obtained.
The results provide a guideline for data collection and parameter identification of these systems.
